Inhibition of Hepatitis B Virus Replication by Homoharringtonine, IFN-α1b, Hydroxycamptothecin and Norfloxacin
暂无分享,去创建一个
The inhibitory effects of homoharringtonine、IFN-α1b 、hydroxycamptothecin and norfloxacin on Hepatitis B virus(HBV)replication in vitro was investigated. Different concentrations of each drug were added to the culture medium of HepG2.2.15 cell line transfected with HBV. The Cytopathic effects ( CPE ) and cell toxicity of each drug was observed. Under the maximum non-toxic conentration(TC0),ELISA and fluorescent quantified PCR were used for determining HBsAg、HBeAg and HBVDNA in the culture medium. The results showed that homoharringtonine and IFN-α1b had an apparent inhibitory effect to HBV while Hydroxycamptothecinhad had only a weak effect to HBV replication. Norfloxacin had no inhibition effect to HBV at any concentration. This data t provide part of the experimental evidence needed to initiate clinical trials to evaluate homoharringtonine as an anti-HBV drub.
[1] B. Cheson,et al. Homoharringtonine , 2001, Cancer.
[2] B. Cheson,et al. Homoharringtonine: history, current research, and future direction. , 2001, Cancer.
[3] P. Galle,et al. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells. , 1998, Arzneimittel-Forschung.
[4] M. Shapiro,et al. Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions , 1988, Journal of virology.